Overview

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Status:
Completed
Trial end date:
2020-03-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, safety, and tolerability of belimumab in adult patients with active lupus nephritis.
Phase:
Phase 3
Details
Lead Sponsor:
Human Genome Sciences Inc., a GSK Company
Collaborator:
GlaxoSmithKline
Treatments:
Belimumab